+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Nutrigenomics Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, and Services), By End User (Hospitals & Clinics, Online Platforms, and Others), By Application, By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 106 Pages
  • February 2024
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5943324
The Latin America, Middle East and Africa Nutrigenomics Market would witness market growth of 18.3% CAGR during the forecast period (2023-2030).

In weight management, it provides insights into how genetic factors influence an individual's response to different diets and exercise regimens. This personalized approach to weight management aims to enhance the effectiveness of interventions, considering factors such as metabolism, appetite regulation, and fat storage. Athletes and fitness enthusiasts increasingly turn to Nutritional genomics to unlock peak performance secrets. Tailoring nutrition plans based on genetic factors related to muscle recovery, energy metabolism, and nutrient utilization can potentially enhance training outcomes and reduce the risk of injuries.

Furthermore, the market is characterized by dynamism, with ongoing trends reflecting technological advancements, research, and consumer preferences. These trends shape the market's trajectory and indicate the direction in which nutrigenomics is evolving as a transformative force in the realm of personalized nutrition. One notable trend in the market is integrating artificial intelligence (AI) for more sophisticated data analysis. AI algorithms interpret complex genetic data, allowing more nuanced and accurate insights into gene-nutrient interactions. This technology enhances the precision of personalized nutrition recommendations and facilitates handling vast datasets generated by genetic testing.

The UAE has witnessed a significant increase in obesity rates over the years, which can be attributed to factors such as sedentary lifestyles, unhealthy dietary habits, and the prevalence of processed foods. It allows for developing personalized nutrition plans based on an individual's genetic profile. Considering the diverse population in the UAE, personalized dietary recommendations can help combat obesity by optimizing nutrient intake, managing weight, and reducing the risk of obesity-related health issues. As per the data released by the United Arab Emirates Ministry of Climate Change & Environment, in the UAE, almost 70 percent of adults are overweight, and 28 percent are obese, with childhood obesity rising per global trends. Thus, rising obesity numbers in LAMEA region is expected to boost the demand for Nutritional genomics in the region.

The Brazil market dominated the LAMEA Nutrigenomics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $31.5 Million by 2030, growing at a CAGR of 17.1 % during the forecast period. The Argentina market is expected to witness a CAGR of 19.2% during (2023 - 2030). Additionally, The UAE market is expected to witness a CAGR of 17.9% during (2023 - 2030).

Based on Product, the market is segmented into Reagents & Kits, and Services. Based on End User, the market is segmented into Hospitals & Clinics, Online Platforms, and Others. Based on Application, the market is segmented into Obesity, Diabetes, Cardiovascular Diseases, and Cancer Research. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Genova Diagnostics
  • Metagenics, Inc.
  • Nutrigenomix Inc.
  • Unilever PLC
  • The Gene Box
  • Cura Integrative Medicine
  • Fagron Genomics S.L.U. (GX Sciences Inc.)
  • Xcode Life Sciences Private Limited
  • DNA Life
  • BASF SE

Market Report Segmentation

By Product
  • Reagents & Kits
  • Services
By End User
  • Hospitals & Clinics
  • Online Platforms
  • Others
By Application
  • Obesity
  • Diabetes
  • Cardiovascular Diseases
  • Cancer Research
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Nutrigenomics Market, by Product
1.4.2 LAMEA Nutrigenomics Market, by End User
1.4.3 LAMEA Nutrigenomics Market, by Application
1.4.4 LAMEA Nutrigenomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. LAMEA Nutrigenomics Market by Product
4.1 LAMEA Reagents & Kits Market by Country
4.2 LAMEA Services Market by Country
Chapter 5. LAMEA Nutrigenomics Market by End User
5.1 LAMEA Hospitals & Clinics Market by Country
5.2 LAMEA Online Platforms Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Nutrigenomics Market by Application
6.1 LAMEA Obesity Market by Country
6.2 LAMEA Diabetes Market by Country
6.3 LAMEA Cardiovascular Diseases Market by Country
6.4 LAMEA Cancer Research Market by Country
Chapter 7. LAMEA Nutrigenomics Market by Country
7.1 Brazil Nutrigenomics Market
7.1.1 Brazil Nutrigenomics Market by Product
7.1.2 Brazil Nutrigenomics Market by End User
7.1.3 Brazil Nutrigenomics Market by Application
7.2 Argentina Nutrigenomics Market
7.2.1 Argentina Nutrigenomics Market by Product
7.2.2 Argentina Nutrigenomics Market by End User
7.2.3 Argentina Nutrigenomics Market by Application
7.3 UAE Nutrigenomics Market
7.3.1 UAE Nutrigenomics Market by Product
7.3.2 UAE Nutrigenomics Market by End User
7.3.3 UAE Nutrigenomics Market by Application
7.4 Saudi Arabia Nutrigenomics Market
7.4.1 Saudi Arabia Nutrigenomics Market by Product
7.4.2 Saudi Arabia Nutrigenomics Market by End User
7.4.3 Saudi Arabia Nutrigenomics Market by Application
7.5 South Africa Nutrigenomics Market
7.5.1 South Africa Nutrigenomics Market by Product
7.5.2 South Africa Nutrigenomics Market by End User
7.5.3 South Africa Nutrigenomics Market by Application
7.6 Nigeria Nutrigenomics Market
7.6.1 Nigeria Nutrigenomics Market by Product
7.6.2 Nigeria Nutrigenomics Market by End User
7.6.3 Nigeria Nutrigenomics Market by Application
7.7 Rest of LAMEA Nutrigenomics Market
7.7.1 Rest of LAMEA Nutrigenomics Market by Product
7.7.2 Rest of LAMEA Nutrigenomics Market by End User
7.7.3 Rest of LAMEA Nutrigenomics Market by Application
Chapter 8. Company Profiles
8.1 Genova Diagnostics
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Metagenics, Inc.
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Acquisition and Mergers:
8.2.3 SWOT Analysis
8.3 Nutrigenomix Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.2.2 Product Launches and Product Expansions:
8.3.3 SWOT Analysis
8.4 Unilever PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 The Gene Box
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 Cura Integrative Medicine
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Fagron Genomics S.L.U. (GX Sciences Inc.)
8.7.1 Company Overview
8.7.2 SWOT Analysis
8.8 Xcode Life Sciences Private Limited
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Product Launches and Product Expansions:
8.8.3 SWOT Analysis
8.9 DNA Life
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. BASF SE
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis

Companies Mentioned

  • Genova Diagnostics
  • Metagenics, Inc.
  • Nutrigenomix Inc.
  • Unilever PLC
  • The Gene Box
  • Cura Integrative Medicine
  • Fagron Genomics S.L.U. (GX Sciences Inc.)
  • Xcode Life Sciences Private Limited
  • DNA Life
  • BASF SE

Methodology

Loading
LOADING...